These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23902726)
1. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. Brunner E; Falk DM; Jones M; Dey DK; Shatapathy CC BMC Pharmacol Toxicol; 2013 Aug; 14():38. PubMed ID: 23902726 [TBL] [Abstract][Full Text] [Related]
2. Outcome of infants exposed to olanzapine during breastfeeding. Gilad O; Merlob P; Stahl B; Klinger G Breastfeed Med; 2011 Apr; 6(2):55-8. PubMed ID: 21034242 [TBL] [Abstract][Full Text] [Related]
3. Duloxetine and pregnancy outcomes: safety surveillance findings. Hoog SL; Cheng Y; Elpers J; Dowsett SA Int J Med Sci; 2013; 10(4):413-9. PubMed ID: 23471302 [TBL] [Abstract][Full Text] [Related]
4. Olanzapine-exposed pregnancies and lactation: early experience. Goldstein DJ; Corbin LA; Fung MC J Clin Psychopharmacol; 2000 Aug; 20(4):399-403. PubMed ID: 10917399 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Coppola D; Russo LJ; Kwarta RF; Varughese R; Schmider J Drug Saf; 2007; 30(3):247-64. PubMed ID: 17343431 [TBL] [Abstract][Full Text] [Related]
6. Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation. Marder SR; Sorsaburu S; Dunayevich E; Karagianis JL; Dawe IC; Falk DM; Dellva MA; Carlson JL; Cavazzoni PA; Baker RW J Clin Psychiatry; 2010 Apr; 71(4):433-41. PubMed ID: 20156413 [TBL] [Abstract][Full Text] [Related]
7. Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature. Teodorescu A; Ifteni P; Moga MA; Burtea V; Bigiu N BMC Psychiatry; 2017 Aug; 17(1):311. PubMed ID: 28851326 [TBL] [Abstract][Full Text] [Related]
8. Healthy outcome under olanzapine treatment in a pregnant woman. Kirchheiner J; Berghöfer A; Bolk-Weischedel D Pharmacopsychiatry; 2000 Mar; 33(2):78-80. PubMed ID: 10761825 [TBL] [Abstract][Full Text] [Related]
9. Long-acting olanzapine injection during pregnancy and breastfeeding: a case report. Manouilenko I; Öhman I; Georgieva J Arch Womens Ment Health; 2018 Oct; 21(5):587-589. PubMed ID: 29637404 [TBL] [Abstract][Full Text] [Related]
10. Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding. Kaplan S; Zeygarnik M; Stern T Drug Saf; 2022 Apr; 45(4):345-357. PubMed ID: 35297004 [TBL] [Abstract][Full Text] [Related]
12. Safety of cetirizine in pregnancy. Golembesky A; Cooney M; Boev R; Schlit AF; Bentz JWG J Obstet Gynaecol; 2018 Oct; 38(7):940-945. PubMed ID: 29565188 [TBL] [Abstract][Full Text] [Related]
13. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143 [TBL] [Abstract][Full Text] [Related]
14. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609 [TBL] [Abstract][Full Text] [Related]
15. Antipsychotic use in pregnancy. Kulkarni J; Storch A; Baraniuk A; Gilbert H; Gavrilidis E; Worsley R Expert Opin Pharmacother; 2015 Jun; 16(9):1335-45. PubMed ID: 26001182 [TBL] [Abstract][Full Text] [Related]